Nothing Special   »   [go: up one dir, main page]

KR960702754A - 생리적으로 활성인 펩티드를 함유하는 질내 투여 제제(vaginal preparation containing physiologically active peptide) - Google Patents

생리적으로 활성인 펩티드를 함유하는 질내 투여 제제(vaginal preparation containing physiologically active peptide)

Info

Publication number
KR960702754A
KR960702754A KR1019950705529A KR19950705529A KR960702754A KR 960702754 A KR960702754 A KR 960702754A KR 1019950705529 A KR1019950705529 A KR 1019950705529A KR 19950705529 A KR19950705529 A KR 19950705529A KR 960702754 A KR960702754 A KR 960702754A
Authority
KR
South Korea
Prior art keywords
physiologically active
containing physiologically
vaginal preparation
preparation containing
peptides
Prior art date
Application number
KR1019950705529A
Other languages
English (en)
Other versions
KR100419558B1 (ko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR960702754A publication Critical patent/KR960702754A/ko
Application granted granted Critical
Publication of KR100419558B1 publication Critical patent/KR100419558B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1019950705529A 1993-06-07 1994-06-02 생리적으로활성인펩티드를함유하는질내투여제제 KR100419558B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP13573893A JP3628713B2 (ja) 1993-06-07 1993-06-07 生理学的に活性なペプチドを含有する膣投与製剤
JP93/135738 1993-06-07

Publications (2)

Publication Number Publication Date
KR960702754A true KR960702754A (ko) 1996-05-23
KR100419558B1 KR100419558B1 (ko) 2004-05-20

Family

ID=15158721

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950705529A KR100419558B1 (ko) 1993-06-07 1994-06-02 생리적으로활성인펩티드를함유하는질내투여제제

Country Status (9)

Country Link
US (2) US5776886A (ko)
EP (1) EP0702958B1 (ko)
JP (1) JP3628713B2 (ko)
KR (1) KR100419558B1 (ko)
AU (1) AU6856194A (ko)
CA (1) CA2164193C (ko)
DE (1) DE69427977T2 (ko)
ES (1) ES2161247T3 (ko)
WO (1) WO1994028918A1 (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3628713B2 (ja) * 1993-06-07 2005-03-16 帝國製薬株式会社 生理学的に活性なペプチドを含有する膣投与製剤
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US7402559B2 (en) 1999-03-24 2008-07-22 Msh Pharma, Incorporated Composition and method of treatment for urogenital conditions
CN1183965C (zh) 2000-02-04 2005-01-12 尤尼金实验室公司 鼻内降钙素制剂
AT409081B (de) * 2000-02-16 2002-05-27 Gebro Pharma Gmbh Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung
WO2003097080A1 (en) * 2002-05-15 2003-11-27 Sun Pharmaceutical Industries Limited A stable aqueous composition of a peptide
DE10248412B4 (de) * 2002-08-01 2009-05-20 Bernd Rauscher Suppositorium zur Behandlung oder Vorbeugung von Hypoglykämie
PT1572106E (pt) 2002-11-15 2010-06-17 Novartis Vaccines & Diagnostic Métodos para prevenção e tratamento de metástase de cancro e perda óssea associada a metástase de cancro
EP1744683B1 (en) * 2004-05-13 2016-03-16 Alza Corporation Apparatus and method for transdermal delivery of parathyroid hormone agents
US8088093B2 (en) * 2008-08-07 2012-01-03 Ottuso Patrick Wound penetrating hemostatic device impregnated with coagulant, antibiotic and/or anesthetic
EP2331075B1 (en) 2008-08-29 2015-07-29 Genzyme Corporation Controlled-released peptide formulations
MX2012009493A (es) * 2010-02-16 2012-12-17 Playtex Products Llc Fibras de bajo ph, potencial de oxidacion-reduccion optimos y reductoras de olores, un proceso para la fabricacion de fibras y articulos hechos con las mismas.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59148717A (ja) * 1983-02-11 1984-08-25 Takeda Chem Ind Ltd 膣投与製剤
JPS6210020A (ja) * 1985-07-08 1987-01-19 Kanebo Ltd カルシトニン含有組成物
JPS62267238A (ja) * 1986-05-15 1987-11-19 R P Shiila- Kk インシユリン坐剤の製法
JPS6339822A (ja) * 1986-08-04 1988-02-20 Yamanouchi Pharmaceut Co Ltd カルシトニン経鼻剤
JPH01230530A (ja) * 1987-11-21 1989-09-14 Toyo Jozo Co Ltd カルシトニン類経鼻投与用液剤組成物
NO179479C (no) * 1988-03-11 1996-10-16 Teikoku Seiyaku Kk Fremgangsmåte for fremstilling av et intravaginalt farmasöytisk preparat
JPH0348627A (ja) * 1989-07-14 1991-03-01 Kanebo Ltd カルシトニン腟坐剤
JPH0381228A (ja) * 1989-08-24 1991-04-05 Kanebo Ltd カルシトニン腟坐剤
JPH04149126A (ja) * 1990-10-09 1992-05-22 Mitsubishi Kasei Corp 経粘膜投与用医薬組成物
CA2070061C (en) * 1991-06-07 2004-02-10 Shigeyuki Takama Physiologically active polypeptide-containing pharmaceutical composition
US5482706A (en) * 1992-04-17 1996-01-09 Takeda Chemical Industries, Ltd. Transmucosal therapeutic composition
JP3628713B2 (ja) * 1993-06-07 2005-03-16 帝國製薬株式会社 生理学的に活性なペプチドを含有する膣投与製剤

Also Published As

Publication number Publication date
US6008189A (en) 1999-12-28
JPH06345665A (ja) 1994-12-20
JP3628713B2 (ja) 2005-03-16
AU6856194A (en) 1995-01-03
CA2164193C (en) 2007-09-18
CA2164193A1 (en) 1994-12-22
ES2161247T3 (es) 2001-12-01
DE69427977T2 (de) 2001-11-29
US5776886A (en) 1998-07-07
WO1994028918A1 (fr) 1994-12-22
EP0702958A1 (en) 1996-03-27
EP0702958A4 (en) 1996-12-04
EP0702958B1 (en) 2001-08-16
KR100419558B1 (ko) 2004-05-20
DE69427977D1 (de) 2001-09-20

Similar Documents

Publication Publication Date Title
EP0845265A4 (en) PREPARATION FOR MUCUSA BASED ON PEPTIDES WITH PHYSIOLOGICAL ACTIVITY
EP0950665A4 (en) PHYSIOLOGICALLY ACTIVE MODIFIED PROTEINS AND DRUG COMPOSITIONS CONTAINING THEM
DE4393381T1 (de) Peptide
TR199501669A1 (tr) Peptid ve proteinlerin aerosol formülasyonlari.
DE69001876D1 (de) Hoch-resorbierbare transvaginale zubereitung mit biologisch aktiven peptiden.
ATA144090A (de) Formulierungen mit verlangsamter freisetzung wasserlöslicher peptide
DE69626397D1 (de) Darifenacin enthaltende pharmazeutische zubereitungen
EP0645136A3 (en) Pharmaceutical preparation of the type: physiologically active substance with sustained release.
BR9607317A (pt) Peptídios e composição farmacêutica
BR9607318A (pt) Peptidos e composição farmacêutica
ATA901092A (de) Teilchen enthaltend biologisch aktives peptid
DK6893D0 (da) Peptid
GB8907148D0 (en) Biologically active proteins
EP0420649A3 (en) Stabilized aqueous formulations of small peptides
KR960702754A (ko) 생리적으로 활성인 펩티드를 함유하는 질내 투여 제제(vaginal preparation containing physiologically active peptide)
EP0340333A3 (en) Novel physiologically active polypeptide and pharmaceutical composition
HRP950612B1 (en) PEPTIDE p277 ANALOGS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM
DE69711267D1 (de) Cyclosporin enthaltende Weichkapselpräparate
AU6428890A (en) Therapeutic peptides and proteins
AU1413488A (en) Pharmacologically active peptides
DE69617396D1 (de) T-Zellen beeinflussende Peptide
ZA936692B (en) Physiologically active peptide composition
EP0129582A4 (en) BIOLOGICALLY ACTIVE PEPTIDES AND PROTEINS FOR ORAL ADMINISTRATION.
EE9800275A (et) Misolastiini sisaldavad prolongeeritud toimega farmatseutilised preparaadid
KR920700222A (ko) 동결건조된 펩티드 제제

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20091230

Year of fee payment: 7

LAPS Lapse due to unpaid annual fee